Design
Review
Authors
Loading...
No immediate change to antiplatelet therapy; leaves open whether targeting platelet inflammation improves ASCVD outcomes.
Key points are not available for this paper at this time.
Projahn et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: